Myocardial dysfunction in long‐term breast cancer survivors treated at ages 40–50 years

AIMS: Anthracyclines increase heart failure (HF) risk, but the long‐term prevalence of myocardial dysfunction in young breast cancer (BC) survivors is unknown. Early measures of left ventricular myocardial dysfunction are needed to identify BC patients at risk of symptomatic HF. METHODS AND RESULTS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobse, Judy N., Steggink, Lars C., Sonke, Gabe S., Schaapveld, Michael, Hummel, Yoran M., Steenbruggen, Tessa G., Lefrandt, Joop D., Nuver, Janine, Crijns, Anne P.G., Aleman, Berthe M.P., van der Meer, Peter, Gietema, Jourik A., van Leeuwen, Flora E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Focus on Cardio‐oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077738/
https://www.ncbi.nlm.nih.gov/pubmed/31696625
http://dx.doi.org/10.1002/ejhf.1610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077738/
https://www.ncbi.nlm.nih.gov/pubmed/31696625
http://dx.doi.org/10.1002/ejhf.1610

Ejemplares similares